Acrongenomics Inc. of Geneva and Molecular Visions Ltd. of London
will combine efforts to develop and commercialize portable point-of-care diagnostic
equipment for medical testing. Potential tests include those for diagnosing diabetes,
drug abuse, sexually transmitted diseases and cardiovascular diseases. The partnership
will draw on the British company’s patented diagnostic chips, technology that
incorporates microfluidics and organic semiconductor devices.
MORE FROM PHOTONICS MEDIA